Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10

Cost–consequence analysis of fluticasone furoate/vilanterol 92/22 mcg for the management of COPD in the Spanish NHS

Total article views   HTML views PDF downloads Totals
7,486 Dovepress* 7,068+ 1,069 8,137
PubMed Central* 418 116 534
Totals 7,486 1,185 8,671
*Since 5 September 2018

View citations on PubMed Central and Google Scholar